SUSTAINED ANTI-INFLAMMATORY EFFECTS OF LUMACAFTOR-IVACAFTOR IN SPUTUM AND PERIPHERAL BLOOD SAMPLES OF ADULT CYSTIC FIBROSIS PATIENTS- AN OBSERVATIONAL STUDY

被引:0
|
作者
Arooj, P. [1 ]
Morrissy, D. [1 ]
Ronan, N. [1 ]
McCarthy, Y. [1 ]
Fleming, C. [1 ]
Eustace, J. A. [1 ]
Murphy, D. M. [1 ]
Plant, B. J. [1 ]
机构
[1] Univ Coll Cork, Cork Univ Hosp, Cork Cyst FThrosis Ctr, Cork, Ireland
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
S27
引用
下载
收藏
页码:A20 / A21
页数:2
相关论文
共 32 条
  • [1] ROCK STUDY in CF: sustained anti-inflammatory effects of lumacaftor-ivacaftor in sputum and peripheral blood samples of adult patients with cystic fibrosis-an observational study
    Arooj, Parniya
    Morrissy, David V.
    McCarthy, Yvonne
    Vagg, Tamara
    McCarthy, Mairead
    Fleming, Claire
    Daly, Mary
    Eustace, Joseph A.
    Murphy, Desmond M.
    Plant, B. J.
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [2] Lumacaftor/ivacaftor: An Observational Study Of Outcomes And Tolerances In Patients With Cystic Fibrosis
    Jennings, M. T.
    Dezube, R.
    Hong, G.
    West, N. E.
    Braun, A.
    Merlo, C.
    Lechtzin, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor
    Jennings, Mark T.
    Dezube, Rebecca
    Paranjape, Shruti
    West, Natalie E.
    Hong, Gina
    Braun, Andrew
    Grant, Jonathan
    Merlo, Christian A.
    Lechtzin, Noah
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (11) : 1662 - 1666
  • [4] LUMACAFTOR-IVACAFTOR TOLERANCE IN CYSTIC FIBROSIS PATIENTS HOMOZYGOUS FOR PHE508DEL CFTR: A SINGLE-CENTER OBSERVATIONAL STUDY
    Taylor, T.
    Brown, R. F.
    Tolle, J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 292 - 292
  • [5] Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis
    Graeber, Simon
    Dopfer, Christian
    Naehrlich, Lutz
    Gyulumyan, Lena
    Scheuermann, Heike
    Hirtz, Stephanie
    Wege, Sabine
    Mairbaeurl, Heimo
    Dorda, Marie
    Hyde, Rebecca
    Bagheri-Hanson, Azadeh
    Rueckes-Nilges, Claudia
    Fischer, Sebastian
    Mall, Marcus A.
    Tuemmler, Burkhard
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] EFFECTS OF LUMACAFTOR-IVACAFTOR THERAPY ON CFTR FUNCTION IN PHE508DEL HOMOZYGOUS PATIENTS WITH CYSTIC FIBROSIS
    Graeber, S. Y.
    Dopfer, C.
    Naehrlich, L.
    Gyulumyan, L.
    Scheuermann, H.
    Hirtz, S.
    Wege, S.
    Mairbaeurl, H.
    Dorda, M.
    Hyde, R.
    Bagheri-Hanson, A.
    Rueckes-Nilges, C.
    Fischer, S.
    Mall, M. A.
    Tummler, B.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 235 - 235
  • [7] Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis
    Graeber, Simon Y.
    Dopfer, Christian
    Naehrlich, Lutz
    Gyulumyan, Lena
    Scheuermann, Heike
    Hirtz, Stephanie
    Wege, Sabine
    Mairbaeurl, Heimo
    Dorda, Marie
    Hyde, Rebecca
    Bagheri-Hanson, Azadeh
    Rueckes-Nilges, Claudia
    Fischer, Sebastian
    Mall, Marcus A.
    Tuemmler, Burkhard
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (11) : 1433 - 1442
  • [8] Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
    Enaud, Raphael
    Lussac-Sorton, Florian
    Charpentier, Elena
    Velo-Suarez, Lourdes
    Guiraud, Jennifer
    Bui, Stephanie
    Fayon, Michael
    Schaeverbeke, Thierry
    Nikolski, Macha
    Burgel, Pierre-Regis
    Hery-Arnaud, Genevieve
    Delhaes, Laurence
    MICROBIOLOGY SPECTRUM, 2023, 11 (02):
  • [9] A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
    Tong, Koliarne
    Dorahy, Douglas
    France, Megan
    Burr, Lucy
    Greville, Hugh
    Visser, Simone
    Middleton, Peter
    Wainwright, Claire
    Barker, Daniel
    Wark, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [10] Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years
    Berges, Julian
    Graeber, Simon Y.
    Haemmerling, Susanne
    Yu, Yin
    Kruempelmann, Arne
    Stahl, Mirjam
    Hirtz, Stephanie
    Scheuermann, Heike
    Mall, Marcus A.
    Sommerburg, Olaf
    FRONTIERS IN PHARMACOLOGY, 2023, 14